Breaking News Instant updates and real-time market news.

BA

Boeing

$350.65

-6.96 (-1.95%)

19:31
11/10/19
11/10
19:31
11/10/19
19:31

Boeing looking to deliver 737 MAX planes as FAA reviews training, WSJ says

Boeing (BA) is looking to deliver 737 MAX aircraft to airlines before the end of the year even if regulators haven't approved related pilot training, according to the Wall Street Journal's Andrew Tangel and Andy Pasztor, citing people familiar with the matter. Airlines have been anxious for Boeing to resume deliveries of the MAX jets and "want to avoid bottlenecks and long waits once the plane is cleared for service," the report added. Additionally, Boeing is running out of parking spaces for the grounded 737 MAX jets. With only two months' of spots remaining, Boeing is looking into other potential storage space, a source said. Reference Link

BA Boeing
$350.65

-6.96 (-1.95%)

10/28/19
RHCO
10/28/19
NO CHANGE
Target $49
RHCO
Sell
Barnes Group price target raised to $49 from $45 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on Barnes Group to $49 after its Q3 earnings beat that was driven by stronger execution and productivity gains. The analyst maintains his Sell rating on the stock however amid continued industrial sector weakness, also pointing to the management cutting its 2019 outlook due to weak short-cycle industrial demand. Ciarmoli adds that while Barnes group saw further momentum in its Aerospace business, the quarter may have marked a peak with MAX aircraft output rate reduced to 42 per month.
10/28/19
JEFF
10/28/19
NO CHANGE
Target $420
JEFF
Buy
Boeing price target lowered to $420 from $430 at Jefferies
Jefferies analyst Sheila Kahyaoglu lowered her price target for Boeing to $420 from $430 while keeping a Buy rating on the shares. With the MAX potentially re-entering service in early 2020 and stepping up in rate in late 2020, the 787 step down and 777X delay "creates a more balanced production profile," Kahyaoglu tells investors in a research note. The analyst models an average of ~$31 per share in free cash flow per year over 2020 to 2022.
10/29/19
BUCK
10/29/19
NO CHANGE
Target $365
BUCK
Neutral
Boeing price target lowered to $365 from $395 at Buckingham
Buckingham analyst Richard Safran lowered his price target for Boeing to $365 from $395 and reiterated his Neutral view, telling investors in a research note that the MAX will likely get certified in 4Q19 or early 1Q20, and after deliveries start, sentiment should improve as investors gain visibility into when cash flow, capital deployment, and orders return to pre-MAX crisis levels. He sees two scenarios going forward, with a "reasonable" chance for both: 1) book to bill returns to greater than 1x and investors continue to value Boeing based on 15-17x free cash flow estimates that grow $1-$2/share per year off of 2021E $30/share or; 2) traffic growth decelerates, Boeing loses market share, book to bill falls to less than1x, and multiples compress to the historical less than 10-12x peak free cash flow.
10/31/19
BERN
10/31/19
DOWNGRADE
Target $61
BERN
Market Perform
Boeing's MAX re-launch to have large impact on Southwest, says Bernstein
Bernstein analyst David Vernon downgraded Southwest (LUV) to Market Perform from Outperform with a $61 price target. In a research note to investors, the analyst says he thinks the market is pricing in all the good news on the return of Boeing's (BA) MAX and not appreciating how disruptive its return could be on either the unit revenue or cost fronts. Vernon says he thinks Boeing's re-launch of the MAX will have disproportionately large impact on Southwest's own unit revenue and require start-up costs that are difficult to anticipate.

TODAY'S FREE FLY STORIES

CEO

Cnooc

$152.36

-2.98 (-1.92%)

05:41
11/19/19
11/19
05:41
11/19/19
05:41
Hot Stocks
Cnooc appoints Xu Keqiang as CEO »

Cnooc announced Xu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$14.88

-0.01 (-0.07%)

05:40
11/19/19
11/19
05:40
11/19/19
05:40
Hot Stocks
JinkoSolar sees FY19 solar module shipments 18 GW to 20.0 GW »

JinkoSolar expects its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 10

    Dec

JKS

JinkoSolar

$14.88

-0.01 (-0.07%)

05:39
11/19/19
11/19
05:39
11/19/19
05:39
Hot Stocks
Breaking Hot Stocks news story on JinkoSolar »

JinkoSolar sees Q4 solar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 10

    Dec

M

Macy's

$16.88

0.02 (0.12%)

05:36
11/19/19
11/19
05:36
11/19/19
05:36
Periodicals
Macy's website breached by hackers in October, The Next Web reports »

Macy's website was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ABBV

AbbVie

$88.71

0.07 (0.08%)

05:35
11/19/19
11/19
05:35
11/19/19
05:35
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

JCDXF

JCDecaux

$0.00

(0.00%)

05:30
11/19/19
11/19
05:30
11/19/19
05:30
Initiation
JCDecaux initiated  »

JCDecaux initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$184.53

0.94 (0.51%)

, ABBV

AbbVie

$88.71

0.07 (0.08%)

05:29
11/19/19
11/19
05:29
11/19/19
05:29
Downgrade
Allergan, AbbVie rating change  »

UBS downgrades Allergan…

AGN

Allergan

$184.53

0.94 (0.51%)

ABBV

AbbVie

$88.71

0.07 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ROK

Rockwell Automation

$197.64

-2.58 (-1.29%)

05:25
11/19/19
11/19
05:25
11/19/19
05:25
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

AGN

Allergan

$184.53

0.94 (0.51%)

05:24
11/19/19
11/19
05:24
11/19/19
05:24
Downgrade
Allergan rating change  »

Allergan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEGXF

Segro

$0.00

(0.00%)

05:22
11/19/19
11/19
05:22
11/19/19
05:22
Downgrade
Segro rating change  »

Segro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$14.88

-0.01 (-0.07%)

05:22
11/19/19
11/19
05:22
11/19/19
05:22
Earnings
JinkoSolar reports Q3 EPS 86c, consensus 83c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 10

    Dec

TRQ

Turquoise Hill

$0.45

(0.00%)

05:20
11/19/19
11/19
05:20
11/19/19
05:20
Hot Stocks
Turquoise Hill notes Administrative Court proceedings in Mongolia »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRARY

Credit Agricole

$0.00

(0.00%)

05:18
11/19/19
11/19
05:18
11/19/19
05:18
Upgrade
Credit Agricole rating change  »

Credit Agricole upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$369.50

-2.05 (-0.55%)

05:16
11/19/19
11/19
05:16
11/19/19
05:16
Hot Stocks
Boeing: Air Astana intends to buy 30 737 MAX airplanes »

Air Astana intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.63

-1.36 (-5.67%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Recommendations
Jefferies still expects Amarin shares to rise toward $30 »

Following the data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BB

BlackBerry

$5.28

-0.195 (-3.56%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Hot Stocks
BlackBerry QNX technology to power Arrival intelligent, autonomous-ready EVs »

BlackBerry and electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 06

    Jan

ATRS

Antares Pharma

$4.28

0.12 (2.88%)

05:10
11/19/19
11/19
05:10
11/19/19
05:10
Hot Stocks
Antares Pharma enters into global development agreement with Idorsia »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XONE

ExOne

$7.00

-0.05 (-0.71%)

, ANSS

Ansys

$238.67

3.63 (1.54%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Hot Stocks
ExOne announces collaboration with Ansys »

ExOne (XONE) and ANSYS…

XONE

ExOne

$7.00

-0.05 (-0.71%)

ANSS

Ansys

$238.67

3.63 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.